Ascendis Pharma A (ASND) Other Non Operating Income (2013 - 2018)

Ascendis Pharma A (ASND) has 5 years of Other Non Operating Income data on file, last reported at $23.6 million in Q4 2018.

• For the quarter ending Q4 2018, Other Non Operating Income changed N/A year-over-year to $23.6 million; the trailing twelve-month figure through Dec 2018 stood at $45.8 million (changed N/A YoY), and the FY2018 full-year result was $24.4 million, changed N/A from the prior year.
• Other Non Operating Income improved to $23.6 million in Q4 2018, from $7.7 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $23.6 million in Q4 2018 to a low of $2.3 million in Q4 2014.
• A 4-year average of $11.5 million and a median of $9.9 million in 2016 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income jumped 990.87% in 2014 and tumbled 35.93% in 2016, its largest moves.
• Tracing ASND's Other Non Operating Income over 4 years: stood at $2.3 million in 2014, then jumped by 415.6% to $12.1 million in 2015, then plunged by 35.93% to $7.7 million in 2016, then soared by 204.81% to $23.6 million in 2018.
• Business Quant data shows ASND's Other Non Operating Income at $23.6 million in Q4 2018, $7.7 million in Q4 2016, and $12.1 million in Q4 2015.